Ian E. Anglin

590 total citations
11 papers, 461 citations indexed

About

Ian E. Anglin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ian E. Anglin has authored 11 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Ian E. Anglin's work include Acute Myeloid Leukemia Research (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Ubiquitin and proteasome pathways (2 papers). Ian E. Anglin is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Ubiquitin and proteasome pathways (2 papers). Ian E. Anglin collaborates with scholars based in United States, Australia and United Kingdom. Ian E. Anglin's co-authors include Natasha Kyprianou, James Partin, Deborah T. Glassman, Antonino Passaniti, Michele Vítolo, Toni Antalis, Sarah Netzel–Arnett, Ronald B. Gartenhaus, Kurtis E. Bachman and William M. Mahoney and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Ian E. Anglin

11 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian E. Anglin United States	10	260	93	92	86	66	11	461
Fernando Abarzúa Japan	13	430 1.7×	46 0.5×	69 0.8×	119 1.4×	63 1.0×	23	710
Izabela Papiewska‐Pająk Poland	13	224 0.9×	130 1.4×	53 0.6×	110 1.3×	49 0.7×	24	408
Raymond Washington United States	8	219 0.8×	93 1.0×	64 0.7×	98 1.1×	32 0.5×	9	424
Jakub Kryczka Poland	13	192 0.7×	104 1.1×	68 0.7×	97 1.1×	35 0.5×	23	381
Magdalena M. Grabowska United States	14	333 1.3×	114 1.2×	42 0.5×	135 1.6×	231 3.5×	19	602
E.U. Sumer Denmark	10	169 0.7×	138 1.5×	35 0.4×	57 0.7×	22 0.3×	12	497
S Bryce United Kingdom	9	335 1.3×	96 1.0×	66 0.7×	177 2.1×	86 1.3×	13	535
B. de Crombrugghe United States	12	289 1.1×	73 0.8×	82 0.9×	70 0.8×	29 0.4×	20	597
Seema Parte United States	17	561 2.2×	115 1.2×	29 0.3×	214 2.5×	37 0.6×	26	840

Countries citing papers authored by Ian E. Anglin

Since Specialization

Citations

This map shows the geographic impact of Ian E. Anglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Anglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Anglin more than expected).

Fields of papers citing papers by Ian E. Anglin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian E. Anglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Anglin. The network helps show where Ian E. Anglin may publish in the future.

Co-authorship network of co-authors of Ian E. Anglin

This figure shows the co-authorship network connecting the top 25 collaborators of Ian E. Anglin. A scholar is included among the top collaborators of Ian E. Anglin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian E. Anglin. Ian E. Anglin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Weniger, Bruce G., et al.. (2017). Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015. Vaccine. 36(4). 427–437. 5 indexed citations

Zhao, Aiping, Zhonghan Yang, Rex Sun, et al.. (2013). SerpinB2 Is Critical to Th2 Immunity against Enteric Nematode Infection. The Journal of Immunology. 190(11). 5779–5787. 31 indexed citations

Anglin, Ian E., et al.. (2011). Glucose‐activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype. Journal of Cellular Biochemistry. 113(1). 282–292. 26 indexed citations

Hyun, Sang Won, Ian E. Anglin, Anguo Liu, et al.. (2011). Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia. Experimental Lung Research. 37(6). 327–343. 17 indexed citations

Tonnetti, Laura, Sarah Netzel–Arnett, Grant A. Darnell, et al.. (2008). SerpinB2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival. Cancer Research. 68(14). 5648–5657. 52 indexed citations

Vítolo, Michele, Ian E. Anglin, William M. Mahoney, et al.. (2007). The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biology & Therapy. 6(6). 856–863. 63 indexed citations

Anglin, Ian E., et al.. (2006). Runx Protein Signaling in Human Cancers. Kluwer Academic Publishers eBooks. 119. 189–215. 19 indexed citations

Sun, Lixin, Michele Vítolo, Meng Qiao, Ian E. Anglin, & Antonino Passaniti. (2004). Regulation of TGFβ1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells. Oncogene. 23(27). 4722–4734. 41 indexed citations

Partin, James, Ian E. Anglin, & Natasha Kyprianou. (2003). Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction. British Journal of Cancer. 88(10). 1615–1621. 92 indexed citations

10.

Anglin, Ian E., Deborah T. Glassman, & Natasha Kyprianou. (2002). Induction of prostate apoptosis by α1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer and Prostatic Diseases. 5(2). 88–95. 65 indexed citations

11.

Glynne-Jones, E, M. E. Harper, Liam T. Seery, et al.. (2001). TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. International Journal of Cancer. 94(2). 178–184. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact